It is a pharmaceutical company and I never once got frustrated in timelines. I have invested in a half dozen over the years and never seen one complete anything without delays. It is very rare with drug development to complete anything on time. Between the government regs,compliance,trial design ,testing delay's and whole host of other things that can go wrong, this is very normal.The one thing the company should have done would be to inform us of delay's and what is causing them. Being up front would have eliminated a lot of shareholder confusion.